Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27861203 | 0.82 | HSP90AB1 (0.35) | TSHRSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL18614768 | 0.78 | KDM4E (0.34) | TSHRKDM4EALDH1A1LMNAMAPT | |
| SCHEMBL351538 | 0.72 | ADRA2A (0.34) | TSHR | |
| SCHEMBL8040746 | 0.72 | — | — | |
| SCHEMBL24010024 | 0.70 | MGAM (0.35) | — | |
| SCHEMBL30866976 | 0.70 | KDM4E (0.30) | KDM4EMAPT | |
| SCHEMBL7645745 | 0.69 | HDAC3 (0.32) | LMNA | |
| SCHEMBL28711477 | 0.69 | SMN1; SMN2 (0.40) | TSHRSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL215851 | 0.69 | — | — | |
| SCHEMBL962831 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096998-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | BioNTech SE (DE) | 2026-04-09 | — | — | US | claimed |
| EP-4605439-A1 | METHOD TO PREPARE AMIDATED POLYMERS | Universiteit Gent (BE) | 2025-08-27 | — | — | EP | claimed |
| EP-4572796-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | BioNTech SE (DE) | 2025-06-25 | — | — | EP | claimed |
| CN-118546102-A | Preparation method of 2- (2-methoxycarbonylethyl) -2-oxazoline | 南京普立蒙医疗科技有限公司 | 2024-08-27 | — | — | CN | claimed |
| WO-2024084076-A1 | METHOD TO PREPARE AMIDATED POLYMERS | UNIVERSITEIT GENT (BE) | 2024-04-25 | — | — | WO | claimed |
| WO-2024068674-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | BioNTech SE (DE) | 2024-04-04 | — | — | WO | claimed |
| CN-108939174-B | Layer-by-layer self-assembled multilayer film of pH response type polyoxazoline-nano silver and preparation method thereof | 浙江大学 | 2020-06-19 | — | — | CN | claimed |
| US-20260096998-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | BioNTech SE (DE) | 2026-04-09 | — | — | US | disclosed |
| US-20260076918-A1 | HETEROTELECHELIC COMPOUNDS | KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) | 2026-03-19 | — | — | US | disclosed |
| US-12440600-B2 | Biocompatible, flexible, haemostatic sheet | CILAG GMBH INTERNATIONAL (CH) | 2025-10-14 | — | — | US | disclosed |
| US-20250271423-A1 | POLYMER CONJUGATE FOR BLOCKING OF NON-SPECIFIC INTERACTIONS IN IMMUNOCHEMICAL ASSAYS, METHOD OF ITS SYNTHESIS AND USE THEREOF | USTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I. | 2025-08-28 | — | — | US | disclosed |
| EP-4605439-A1 | METHOD TO PREPARE AMIDATED POLYMERS | Universiteit Gent (BE) | 2025-08-27 | — | — | EP | disclosed |
| EP-4004085-B1 | POLYOXAZOLINE COPOLYMER COMPRISING CALCIUM BINDING GROUPS | CILAG GMBH INT (CH) | 2025-07-30 | — | — | EP | disclosed |
| US-6389970-B1 | WATERPROOF SUPPORT; IMAGE RECEIVER | FUJI PHOTO FILM CO., LTD. (JP) | 2002-05-21 | — | — | US | disclosed |
| US-20020056389-A1 | WATER RESISTANT SUPPORT HAVING IMAGE-RECEIVING LAYER COMPRISING METAL OXIDE OR HYDROXIDE PARTICLES, BINDER, AND A POLYMER CAPABLE OF FORMING A HYDROGEN BOND WITH BINDER RESIN HAVING A CARBOXY GROUP, A SULFO GROUP OR A PHOSPHONO GROUP | FUJIFILM CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| US-20020017208-A1 | Lithographic printing method | FUJI PHOTO FILM CO.,LTD. | 2002-02-14 | — | — | US | disclosed |
| US-20010018155-A1 | Direct drawing type lithographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2001-08-30 | — | — | US | disclosed |
| US-6258512-B1 | PHOTOSENSITIVE LAYER CONTAINING TITANIUM OXIDE GRAINS AND BLEND CONTAINING ORGANOMETALLIC POLYMER | FUJI PHOTO FILM CO., LTD. (JP) | 2001-07-10 | — | — | US | disclosed |
| US-6183923-B1 | CAPABLE OF PROVIDING PRINTING PLATE WHICH ENABLES TO PRINT GREAT NUMBER OF PRINTED MATTER HAVING CLEAR IMAGES FREE FROM BACKGROUND STAINS | FUJI PHOTO FILM CO., LTD. (JP) | 2001-02-06 | — | — | US | disclosed |
| US-5576165-A | PHENOLIC COMPOUND AND POLYMER; STORAGE STABILITY; ANTIFOGGING AGENTS; LATENT IMAGES | FUJI PHOTO FILM CO., LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076918-A1 | HETEROTELECHELIC COMPOUNDS | LDLR, MSR1, LPAR2 | TSHR 160/4885SMN1; SMN2 1592/4885KMT2A 2449/4885 |
| US-20260096998-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | RBM22, PBRM1, RNMT | TSHR 1400/4885SMN1; SMN2 308/4885KMT2A 251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.